<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Although many patients now survive the short-term complications of bone marrow transplantation for life-threatening <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">hematologic disease</z:e>, information on the health and activity of long-term survivors is sparse </plain></SENT>
<SENT sid="1" pm="."><plain>OBJECTIVE: To evaluate the morbidity and mortality of patients surviving more than 5 years after allogeneic bone marrow transplantation </plain></SENT>
<SENT sid="2" pm="."><plain>DESIGN: Retrospective, multicenter study </plain></SENT>
<SENT sid="3" pm="."><plain>PATIENTS: 798 recipients of bone marrow transplants (477 adults, 321 children) from 43 European centers </plain></SENT>
<SENT sid="4" pm="."><plain>Patients had received transplants before December 1985 and had survived at least 5 years </plain></SENT>
<SENT sid="5" pm="."><plain>Patients had received allogeneic or syngeneic bone marrow for <z:hpo ids='HP_0001909'>leukemia</z:hpo>, <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, inborn diseases of the hematopoietic and immune systems, and severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>MEASUREMENTS: Survival, clinical performance according to Karnofsky score (in increments of 10%), and social reintegration were assessed as outcomes </plain></SENT>
<SENT sid="7" pm="."><plain>Patient age and sex, <z:e sem="disease" ids="C0277554" disease_type="Disease or Syndrome" abbrv="">primary disease</z:e> and status at transplantation, histocompatibility of the donor, conditioning regimen, type of prophylaxis of <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e>, and <z:hpo ids='HP_0011009'>acute</z:hpo> and <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> were evaluated as variables </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: For the 55 5-year survivors, actuarial mortality was 8% at 10 years and 14% at 15 years </plain></SENT>
<SENT sid="9" pm="."><plain>The leading causes of <z:hpo ids='HP_0011420'>death</z:hpo> were disease recurrence (21 patients), <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> with complicating <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> and <z:e sem="disease" ids="C0024115" disease_type="Disease or Syndrome" abbrv="">lung disease</z:e> (11 patients), <z:e sem="disease" ids="C0751623" disease_type="Neoplastic Process" abbrv="">secondary cancer</z:e> (8 patients), and the acquired <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> syndrome (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e>) (5 patients) </plain></SENT>
<SENT sid="10" pm="."><plain>When patients with <z:e sem="disease" ids="C0277556" disease_type="Disease or Syndrome" abbrv="">recurrent disease</z:e> were excluded, late <z:hpo ids='HP_0011420'>death</z:hpo> was associated with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> (P &lt; 0.001), occurrence of <z:e sem="disease" ids="C0751623" disease_type="Neoplastic Process" abbrv="">secondary cancer</z:e> (P &lt; 0.001), male sex of the patient (P = 0.05), and female sex of the donor (P = 0.002) </plain></SENT>
<SENT sid="11" pm="."><plain>Clinical performance was <z:mpath ids='MPATH_458'>normal</z:mpath> (Karnofsky score, 100%) or minimally reduced (Karnofsky score, 90%) in 93% of patients; 89% of patients resumed full-time work or school </plain></SENT>
<SENT sid="12" pm="."><plain>Reduced performance status and incomplete resumption of social activity were associated with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e>, recurrent <z:hpo ids='HP_0001909'>leukemia</z:hpo>, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e>, <z:e sem="disease" ids="C0751623" disease_type="Neoplastic Process" abbrv="">secondary cancer</z:e>, organ dysfunction, and neurologic or <z:e sem="disease" ids="C1306597" disease_type="Mental or Behavioral Dysfunction" abbrv="">psychological problems</z:e> </plain></SENT>
<SENT sid="13" pm="."><plain>Other risk factors for incomplete resumption of social activity were female sex (P = 0.002) and older age at transplantation (P = 0.001) </plain></SENT>
<SENT sid="14" pm="."><plain>CONCLUSIONS: More than 5 years after bone marrow transplantation, most patients were in good health (93%) and had returned to full-time work or school (89%) </plain></SENT>
<SENT sid="15" pm="."><plain>Recurrence of the <z:e sem="disease" ids="C0277554" disease_type="Disease or Syndrome" abbrv="">primary disease</z:e>, <z:e sem="disease" ids="C0751623" disease_type="Neoplastic Process" abbrv="">secondary cancer</z:e>, and <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> and its sequelae remain problems for some patients </plain></SENT>
</text></document>